Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-09-113761PMID 17986662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer immunoediting by GITR (glucocorticoid‐induced TNF‐related protein) ligand in humans: NK cell/tumor cell interactions

  2007cited by this paper
• Toll-like receptor 2 controls expansion and function of regulatory T cells.

  2006cited by this paper
• Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).

  2006cited by this paper
• The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

  2006cited by this paper
• Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination1

  2006cited by this paper
• In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

  2006cited by this paper
• NY-ESO-1: review of an immunogenic tumor antigen.

  2006cited by this paper
• Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1

  2005cited by this paper
• In Vivo Kinetics of GITR and GITR Ligand Expression and Their Functional Significance in Regulating Viral Immunopathology

  2005cited by this paper
• Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.

  2005cited by this paper
• The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

  2005cited by this paper
• Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

  2005cited by this paper
• Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function

  2005cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005cited by this paper
• Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

  2005cited by this paper
• Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.

  2005cited by this paper
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

  2005cited by this paper
• CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

  2005cited by this paper
• Autoreactive T Cells in Healthy Individuals1

  2004cited by this paper
• Toll-dependent control mechanisms of CD4 T cell activation.

  2004cited by this paper
• Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance

  2004cited by this paper
• GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease

  2004cited by this paper
• Autoreactive T Cells in Healthy Individuals

  2004cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper
• CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

  2003cited by this paper
• Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

  2003cited by this paper
• Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

  2003cited by this paper
• Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

  2003cited by this paper
• Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

  2003cited by this paper
• Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells

  2003cited by this paper
• Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.

  2003cited by this paper
• Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance

  2002cited by this paper
• Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

  2002cited by this paper
• CD4+CD25+ suppressor T cells: more questions than answers

  2002cited by this paper
• Salmonella interactions with host cells: type III secretion at work.

  2001cited by this paper
• Regulatory T cells in the control of immune pathology

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.

  2001cited by this paper
• Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

  2000cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

  1998cited by this paper
• Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

  1998cited by this paper
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

  1997cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Human neoplasms elicit multiple specific immune responses in the autologous host.

  1995cited by this paper

• NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy

  2024cites this paper
• Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment

  2023cites this paper
• MiR‐363‐5p modulates regulatory T cells through STAT4‐HSPB1‐Notch1 axis and is associated with the immunological abnormality in Graves' disease

  2021cites this paper
• Engineering Living Bacteria for Cancer Therapy.

  2020cites this paper
• High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells

  2019cites this paper
• Development of Salmonella-Based Cancer Vaccines

  2015cites this paper
• Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes

  2013cites this paper
• Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells

  2013cites this paper
• Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic.

  2013cites this paper
• Cancer Therapy : Preclinical Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow : A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells

  2013cites this paper
• Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

  2012cites this paper
• Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine

  2012cites this paper
• Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

  2011cites this paper
• Costimulation In Vivo GITR Ligand − Dependent upon, GITR Therapeutically Enhanced by, but Are Not Th2 Responses to Helminth Parasites Can Be

  2011cites this paper
• Process, development for industrial scale bacterial ghost production

  2011cites this paper
• Th2 Responses to Helminth Parasites Can Be Therapeutically Enhanced by, but Are Not Dependent upon, GITR–GITR Ligand Costimulation In Vivo

  2011cites this paper
• Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity

  2011cites this paper
• 3‐Methylcholanthrene‐induced transforming growth factor‐β‐producing carcinomas, but not sarcomas, are refractory to regulatory T cell‐depletion therapy

  2010cites this paper
• This month in APR

  2010cites this paper
• Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

  2010cites this paper
• Regulatory T cells in tumor immunity

  2010cites this paper
• The bacterial ghost platform system

  2010cites this paper
• Bacterial ghosts (BGs)--advanced antigen and drug delivery system.

  2010cites this paper
• Therapeutic Immunity by Adoptive Tumor-primed CD4+ T-cell Transfer in Combination With In Vivo GITR Ligation.

  2009cites this paper
• Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes

  2009cites this paper
• Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

  2009cites this paper
• Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.

  2009cites this paper
• Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation.

  2009cites this paper
• Characterization of Preexisting MAGE-A3-Specific CD4+ T Cells in Cancer Patients and Healthy Individuals and Their Activation by Protein Vaccination1

  2009cites this paper
• Activation by Protein Vaccination Patients and Healthy Individuals and Their T Cells in Cancer + MAGE-A3-Specific CD4 Characterization of Preexisting

  2009cites this paper
• NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells

  2009cites this paper
• Glucocorticoid‐induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen‐specific CD8+ T cells with tumor regression

  2009cites this paper
• Identification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells

  2009cites this paper
• Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

  2008cites this paper
• With Broad Antigen Specificity T Cell Responses + and Cd4 + Human Cd8 Receptor or Dec-205 in Vitro Elicits Dual Antibody-targeted Ny-eso-1 to Mannose

  year unknowncites this paper